15.6 C
New York
Tuesday, April 23, 2024

Hearing Amylin Considering Sale -Reuters

Courtesy of Benzinga.

Amylin (NASDAQ: AMLN) is considering a sale of the company, according to sources cited by Reuters. Amylin is attempting to fight off a law suit by investor Carl Icahn. The company recently rejected a $3.5 billion takeover offer from Bristol-Myers Squibb (NYSE: BMY).


For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,336FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x